DK0981334T3 - Slugetabletter indeholdende paracetamol - Google Patents

Slugetabletter indeholdende paracetamol

Info

Publication number
DK0981334T3
DK0981334T3 DK98913664T DK98913664T DK0981334T3 DK 0981334 T3 DK0981334 T3 DK 0981334T3 DK 98913664 T DK98913664 T DK 98913664T DK 98913664 T DK98913664 T DK 98913664T DK 0981334 T3 DK0981334 T3 DK 0981334T3
Authority
DK
Denmark
Prior art keywords
tablets containing
swallowing tablets
containing paracetamol
paracetamol
swallowing
Prior art date
Application number
DK98913664T
Other languages
Danish (da)
English (en)
Inventor
Timothy James Grattan
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Application granted granted Critical
Publication of DK0981334T3 publication Critical patent/DK0981334T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/485Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Detergent Compositions (AREA)
DK98913664T 1997-03-05 1998-02-27 Slugetabletter indeholdende paracetamol DK0981334T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9704524.9A GB9704524D0 (en) 1997-03-05 1997-03-05 Composition
PCT/EP1998/001284 WO1998038983A2 (en) 1997-03-05 1998-02-27 Swallow tablet comprising paracetamol

Publications (1)

Publication Number Publication Date
DK0981334T3 true DK0981334T3 (da) 2003-09-22

Family

ID=10808717

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98913664T DK0981334T3 (da) 1997-03-05 1998-02-27 Slugetabletter indeholdende paracetamol

Country Status (36)

Country Link
US (1) US6316025B1 (de)
EP (1) EP0981334B1 (de)
JP (1) JP2001513801A (de)
KR (1) KR100465895B1 (de)
CN (1) CN100389751C (de)
AP (1) AP1084A (de)
AR (1) AR011919A1 (de)
AT (1) ATE240720T1 (de)
AU (1) AU721851B2 (de)
BG (1) BG64348B1 (de)
BR (1) BR9807992A (de)
CA (1) CA2283408C (de)
CO (1) CO4940406A1 (de)
CY (1) CY2367B1 (de)
CZ (1) CZ294078B6 (de)
DE (1) DE69814850T2 (de)
DK (1) DK0981334T3 (de)
EA (1) EA001918B1 (de)
ES (1) ES2199435T3 (de)
GB (1) GB9704524D0 (de)
HK (1) HK1027026A1 (de)
HU (1) HU224983B1 (de)
ID (1) ID22233A (de)
IL (1) IL131552A (de)
MY (1) MY119722A (de)
NO (1) NO327456B1 (de)
NZ (1) NZ337418A (de)
PE (1) PE68899A1 (de)
PL (1) PL190988B1 (de)
PT (1) PT981334E (de)
SK (1) SK282277B6 (de)
TR (1) TR199902175T2 (de)
TW (1) TW508242B (de)
UA (1) UA59388C2 (de)
WO (1) WO1998038983A2 (de)
ZA (1) ZA981832B (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6211246B1 (en) 1999-06-10 2001-04-03 Mcneil-Ppc, Inc. Rapidly absorbed liquid compositions
NZ508291A (en) * 1999-11-24 2002-09-27 Mcneil Ppc Inc Use of acetaminophen in a medicament for treating migraine symptoms
GB0006897D0 (en) * 2000-03-23 2000-05-10 Smithkline Beecham Plc Medicaments
GB0114069D0 (en) 2001-06-08 2001-08-01 Smithkline Beecham Plc Composition
GB0129117D0 (en) * 2001-12-05 2002-01-23 Glaxo Group Ltd Pharmaceutical composition
WO2004089365A1 (en) * 2003-04-11 2004-10-21 Pfizer Limited Pharmaceutical combination comprising eletriptan and sodium bicarbonate
US8216610B2 (en) * 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
WO2005115344A1 (en) * 2004-05-28 2005-12-08 Imaginot Pty Ltd Oral delivery system
JP2008500288A (ja) * 2004-05-28 2008-01-10 イメイジノット ピーティーワイ エルティーディー 経口治療用化合物の供給系
DE102004042139B4 (de) * 2004-08-31 2009-06-10 Aristocon Verwaltungs- Gmbh Perorale Darreichungsformen zur Erzielung eines Retardierungseffektes nach der Arzneimitteleinnahme mit einer Mahlzeit
BRPI0520000A2 (pt) * 2004-10-28 2009-04-07 Novartis Ag composição compreendendo acetaminofeno, cafeìna e opcionalmente aspirina juntos com um agente alcalino para absorção intensificada
US9060950B2 (en) * 2005-06-13 2015-06-23 Paul H. Rosenberg, Proximate Concepts, LLC. Emetic embedded capsule
WO2006138278A1 (en) * 2005-06-13 2006-12-28 Paul Rosenberg Emetic embedded capsule
KR100702069B1 (ko) * 2005-10-31 2007-03-30 (주)이엘티사이언스 파라세타몰 경구용 수용산제 복합조성물 및 그 제조방법
AU2006317530B2 (en) 2005-11-28 2011-09-01 Imaginot Pty Ltd Oral therapeutic compound delivery system
GB0607085D0 (en) * 2006-04-07 2006-05-17 Smithkline Beecham Corp Novel compositions
US20080014228A1 (en) * 2006-07-14 2008-01-17 Olivia Darmuzey Solid form
US20080311162A1 (en) * 2007-05-16 2008-12-18 Olivia Darmuzey Solid form
WO2009019555A2 (en) * 2007-08-07 2009-02-12 Stellenbosch University Ophthalmic formulation containing paracetamol
KR101687580B1 (ko) 2016-07-19 2016-12-20 주식회사 씨.월드 의자 등받이부와 프레임부 조립구조
AU2019383389A1 (en) 2018-11-19 2021-05-06 Jazz Pharmaceuticals Ireland Limited Alcohol-resistant drug formulations

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1182049A (en) * 1981-07-13 1985-02-05 Francis J. Sterbenz Apap antacid composition
US4942039A (en) * 1989-05-09 1990-07-17 Miles Inc. Effervescent analgesic antacid composition having reduced sodium content
ES2060736T3 (es) * 1989-01-12 1994-12-01 Bayer Ag Composicion antiacida analgesica efervescente con un contenido en sodio reducido.
US5348745A (en) * 1989-05-09 1994-09-20 Miles Inc. Aqueous granulation solution and a method of tablet granulation
CA2021548A1 (en) * 1989-09-01 1991-03-02 Ronald Nash Duvall Effervescent cold or sinus allergy medicine composition having reduced sodium content
DE19502789A1 (de) 1995-01-28 1996-08-01 Dirk Krischenowski Arzneimittel

Also Published As

Publication number Publication date
TW508242B (en) 2002-11-01
KR20000075897A (ko) 2000-12-26
AU721851B2 (en) 2000-07-13
PT981334E (pt) 2003-10-31
HU224983B1 (en) 2006-05-29
JP2001513801A (ja) 2001-09-04
CO4940406A1 (es) 2000-07-24
SK119799A3 (en) 2000-02-14
TR199902175T2 (xx) 1999-12-21
HUP0001501A3 (en) 2001-01-29
DE69814850D1 (de) 2003-06-26
CN1253497A (zh) 2000-05-17
BR9807992A (pt) 2000-03-08
EA001918B1 (ru) 2001-10-22
US6316025B1 (en) 2001-11-13
ES2199435T3 (es) 2004-02-16
PL335502A1 (en) 2000-04-25
HK1027026A1 (en) 2001-01-05
CY2367B1 (en) 2004-06-04
HUP0001501A2 (hu) 2000-09-28
DE69814850T2 (de) 2004-03-11
BG103714A (en) 2000-05-31
ID22233A (id) 1999-09-23
NO994294L (no) 1999-09-03
NO994294D0 (no) 1999-09-03
PE68899A1 (es) 1999-09-26
KR100465895B1 (ko) 2005-01-13
AR011919A1 (es) 2000-09-13
ATE240720T1 (de) 2003-06-15
CA2283408A1 (en) 1998-09-11
AP1084A (en) 2002-07-23
MY119722A (en) 2005-07-29
CZ314899A3 (cs) 2000-03-15
CZ294078B6 (cs) 2004-09-15
CA2283408C (en) 2007-01-02
BG64348B1 (bg) 2004-11-30
AU6828298A (en) 1998-09-22
SK282277B6 (sk) 2002-01-07
UA59388C2 (uk) 2003-09-15
WO1998038983A3 (en) 1998-12-17
IL131552A0 (en) 2001-01-28
WO1998038983A2 (en) 1998-09-11
GB9704524D0 (en) 1997-04-23
NO327456B1 (no) 2009-07-06
EP0981334B1 (de) 2003-05-21
IL131552A (en) 2004-08-31
ZA981832B (en) 1998-12-11
AP9901638A0 (en) 1999-09-30
PL190988B1 (pl) 2006-02-28
EP0981334A1 (de) 2000-03-01
CN100389751C (zh) 2008-05-28
NZ337418A (en) 2000-05-26
EA199900709A1 (ru) 2000-08-28

Similar Documents

Publication Publication Date Title
DK0981334T3 (da) Slugetabletter indeholdende paracetamol
IS5524A (is) Forðatöflur til inntöku
IS5541A (is) Áfangatöflur til inntöku
NO20001776L (no) Medikamenter
ATE268161T1 (de) Bioadhäsive tabletten
DE69814367D1 (de) Filmueberzogene tabletten von oxacarbazepin
DE69820407D1 (de) Blisterpackung
ID23735A (id) Tablet trovafloksasin mesilat
DK1017392T3 (da) Lægemiddel
DK1392271T3 (da) Slugetablet indeholdende paracetamol
DE59801987D1 (de) Pharmazeutische zusammensetzung enthaltend peptichemio
DK1069896T3 (da) Lægemidler indeholdende carvedilol
ID29294A (id) Komposisi farmasi
ID25857A (id) Komposisi farmasi
ID23531A (id) Komposisi farmasi
FR2772264B1 (fr) Pilulier
KR950022649U (ko) 약탕기
SI0981334T1 (en) Swallow tablet comprising paracetamol
UA2855S (uk) Таблетка фармацевтична
KR970058612U (ko) 스터디 캡슐
DE69923058D1 (de) Tablettenverpackung
ID21180A (id) Senyawa-senyawa farmasi
NO973300D0 (no) Smokk
UA25523A (uk) Лікувальhий препарат гірчичhик
UA2845S (uk) Таблетка